- Home
- MDAI vs BNR Comparison
MDAI vs BNR Comparison
Compare MDAI & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- BNR
- Stock Information
- Founded
- MDAI 2013
- BNR 2014
- Country
- MDAI United States
- BNR China
- Employees
- MDAI N/A
- BNR N/A
- Industry
- MDAI Medical/Dental Instruments
- BNR Medical Specialities
- Sector
- MDAI Health Care
- BNR Health Care
- Exchange
- MDAI Nasdaq
- BNR Nasdaq
- Market Cap
- MDAI 27.8M
- BNR 30.9M
- IPO Year
- MDAI N/A
- BNR 2020
- Fundamental
- Price
- MDAI $1.25
- BNR $2.94
- Analyst Decision
- MDAI Strong Buy
- BNR
- Analyst Count
- MDAI 2
- BNR 0
- Target Price
- MDAI $4.75
- BNR N/A
- AVG Volume (30 Days)
- MDAI 341.2K
- BNR 20.3K
- Earning Date
- MDAI 05-06-2025
- BNR 05-28-2025
- Dividend Yield
- MDAI N/A
- BNR N/A
- EPS Growth
- MDAI N/A
- BNR N/A
- EPS
- MDAI N/A
- BNR N/A
- Revenue
- MDAI $29,581,000.00
- BNR $70,669,261.00
- Revenue This Year
- MDAI N/A
- BNR $136.32
- Revenue Next Year
- MDAI $102.58
- BNR N/A
- P/E Ratio
- MDAI N/A
- BNR N/A
- Revenue Growth
- MDAI 63.83
- BNR N/A
- 52 Week Low
- MDAI $0.82
- BNR $2.62
- 52 Week High
- MDAI $3.25
- BNR $8.99
- Technical
- Relative Strength Index (RSI)
- MDAI 44.43
- BNR 24.38
- Support Level
- MDAI $1.17
- BNR $2.77
- Resistance Level
- MDAI $1.28
- BNR $3.29
- Average True Range (ATR)
- MDAI 0.09
- BNR 0.30
- MACD
- MDAI 0.02
- BNR 0.01
- Stochastic Oscillator
- MDAI 44.95
- BNR 13.82
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.